Back to Search Start Over

Analysis of the C9orf72 gene in patients with amyotrophic lateral sclerosis in Spain and different populations worldwide

Authors :
Miguel González-Muñoz
Catalina I
Capablo Jl
Guitart M
Ramírez-Ramos C
Márquez-Infante C
García-Barcina M
Pablo Villoslada
Ricardo Rojas-García
Hernández-Barral M
Jordi Pérez-Tur
José Luis Muñoz-Blanco
Pau Pastor
Guerrero A
Juárez-Rufián A
Julio Pardo
Varona L
Moreno-Laguna S
Teresa Sevilla
María-Jesús Sobrido
Paradas C
Ana Gorostidi
Beatriz Quintáns
Larrodé P
A. Lleo
Jesús Esteban-Pérez
de Rivera Fj
Alcalá C
López de Munain A
Goñi M
Rafael Blesa
Kapetanovic S
Cordero-Vázquez P
Poza Jj
Pascual-Calvet J
Roberto Fernandez-Torron
Morán Y
Sarasola E
Morgado Y
Gonzalo-Martínez Jf
Atencia G
Mònica Povedano
Mascías J
Cemillán C
Martín-Estefanía C
Alberto García-Redondo
Jordi Clarimón
Jiménez-Bautista R
Rueda A
de Arcaya Aá
Vela A
Ivonne Jericó
Jesus S. Mora
Galán L
Oriol Dols-Icardo
Fundación Española para el Fomento de la Investigación de la Esclerosis Lateral Amiotrófica
Ministerio de Ciencia e Innovación (España)
Instituto de Salud Carlos III
Centro Investigación Biomédica en Red Enfermedades Neurodegenerativas (España)
Source :
HUMAN MUTATION, r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe, instname, Digital.CSIC. Repositorio Institucional del CSIC
Publication Year :
2013
Publisher :
WILEY, 2013.

Abstract

The C9ORF72 Spanish Study Group, et al.<br />A hexanucleotide repeat expansion in chromosome 9 open reading frame 72 (C9orf72) can cause amyotrophic lateral sclerosis (ALS) and/or frontotemporal dementia (FTD). We assessed its frequency in 781 sporadic ALS (sALS) and 155 familial ALS (fALS) cases, and in 248 Spanish controls. We tested the presence of the reported founder haplotype among mutation carriers and in 171 Ceph Europeans from Utah (CEU), 170 Yoruba Africans, 81 Han Chinese, and 85 Japanese subjects. The C9orf72 expansion was present in 27.1% of fALS and 3.2% of sALS. Mutation carriers showed lower age at onset (P = 0.04), shorter survival (P = 0.02), greater co-occurrence of FTD (P = 8.2 × 10-5), and more family history of ALS (P = 1.4 × 10-20), than noncarriers. No association between alleles within the normal range and the risk of ALS was found (P = 0.12). All 61 of the mutation carriers were tested and a patient carrying 28 hexanucleotide repeats presented with the founder haplotype. This haplotype was found in 5.6% Yoruba Africans, 8.9% CEU, 3.9% Japanese, and 1.6% Han Chinese chromosomes. © 2012 Wiley Periodicals, Inc.<br />We acknowledge the ALS Research Spanish Foundation (FUNDELA) and the UTE project FIMA (Spain) for their help to P.P. Contract grant sponsors: Neuromuscular Database Project, CIBERNED (PI 2010/11); MICINN (SAF2010-10434); ISCIII (PI10/00092 and EC08/00049).

Details

ISSN :
10597794
Database :
OpenAIRE
Journal :
HUMAN MUTATION, r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe, instname, Digital.CSIC. Repositorio Institucional del CSIC
Accession number :
edsair.doi.dedup.....dec6cb6c456917f363f1263be2523008